These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17024558)

  • 1. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors.
    Marrelli D; Pedrazzani C; Neri A; Corso G; DeStefano A; Pinto E; Roviello F
    Ann Surg Oncol; 2007 Jan; 14(1):25-33. PubMed ID: 17024558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
    Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
    Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
    Schmid A; Thybusch A; Kremer B; Henne-Bruns D
    Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
    Wu CW; Hsiung CA; Lo SS; Hsieh MC; Shia LT; Whang-Peng J
    Br J Surg; 2004 Mar; 91(3):283-7. PubMed ID: 14991627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).
    Tsujinaka T; Sasako M; Yamamoto S; Sano T; Kurokawa Y; Nashimoto A; Kurita A; Katai H; Shimizu T; Furukawa H; Inoue S; Hiratsuka M; Kinoshita T; Arai K; Yamamura Y;
    Ann Surg Oncol; 2007 Feb; 14(2):355-61. PubMed ID: 17146738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
    Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
    Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery?
    Pacelli F; Bossola M; Rosa F; Tortorelli AP; Papa V; Doglietto GB
    Clin Nutr; 2008 Jun; 27(3):398-407. PubMed ID: 18436350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of stomach cancer: analysis of our personal experience].
    Leggeri A; Roseano M; Bortul M; Calligaris L
    Chir Ital; 1997; 49(3):15-20. PubMed ID: 9612647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
    Sun D; Gong R; Wu H
    Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
    Reis E; Kama NA; Doganay M; Atli M; Dolapci M
    Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: prospective cohort study.
    Jeong O; Park YK; Ryu SY; Kim YJ
    Ann Surg Oncol; 2010 Jun; 17(6):1589-96. PubMed ID: 20099039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.